Burkholderia vietnamiensis

From WikiMD's WELLNESSPEDIA

Burkholderia vietnamiensis is a bacterial species belonging to the genus Burkholderia. It is a gram-negative, motile, rod-shaped organism that is known for its ability to degrade environmental pollutants and its potential use in bioremediation.

Taxonomy[edit]

Burkholderia vietnamiensis is a member of the Burkholderia cepacia complex, a group of closely related species that are often associated with lung infections in individuals with cystic fibrosis. The species was first described in 1996 and was named after Vietnam, where the first isolates were discovered.

Characteristics[edit]

Burkholderia vietnamiensis is a aerobic, non-spore-forming organism. It is capable of nitrogen fixation, a process that converts atmospheric nitrogen into a form that can be used by plants. This makes B. vietnamiensis a potential candidate for use in sustainable agriculture.

Pathogenicity[edit]

While Burkholderia vietnamiensis is primarily known for its environmental roles, it can also act as an opportunistic pathogen, particularly in individuals with cystic fibrosis. Infections caused by B. vietnamiensis can be difficult to treat due to the organism's inherent resistance to many antibiotics.

Bioremediation[edit]

Burkholderia vietnamiensis has been studied for its potential use in bioremediation, the use of living organisms to degrade environmental pollutants. The organism has been shown to degrade a variety of compounds, including polychlorinated biphenyls and dioxins.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.